bibliographicCitation |
Da Wang F, Zhou J, Li LQ, Li YJ, Wang ML, Tao YC, Zhang DM, Wang YH, Chen EQ. Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir. Ann Hepatol. 2023 Sep;28(5):101119. doi: 10.1016/j.aohep.2023.101119. PMID: 37271480. |